HIGHLIGHTS
- who: Tomohiro Mitoma from the The EPOK trial is a two-arm exploratory double-blinded RCT with a, week intervention period, and the outcomes will be measured at baseline, months, and , monthsFigure , outlines the RCT phases. Eighty participants will be identified and randomly categorised into two groups: (1) MREP with transdermal oestrogen gel and (2) MREP with placebo gel. Eligibility will be assessed during screening. The Okayama University Hospital and Ochiai Hospital will conduct this trial. We have organised the EPOK trial team, including the Maniwa City Community General Support Center, which will assist with recruitment via . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.